1 Result(s)

Article

Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α

Sorafenib resistance is one of the main obstacles to the treatment of advanced/recurrent hepatocellular carcinoma (HCC). Here, sorafenib-resistant HCC cells and xenografts in nude mice were used as experimenta...

Yongxin Qiu, Wenqi Shan, Ye Yang, Ming **, Yi Dai, Hanyu Yang… in Cell Death Discovery (2019)